Showing results (41-50 of 548) with videos related to
Sort By:
Pageof 55
Kidney International|February 5, 2010
Hemodiafiltration: clinical evidence and remaining questionsPeter J Blankestijn, Ingrid Ledebo, Bernard CanaudContributions to Nephrology|October 13, 2010
Optimal therapeutic conditions for online hemodiafiltrationBernard Canaud, Leila Chenine, Sophie Renaud, et al.Contributions to Nephrology|May 3, 2008
Cross-membrane flux is a major factor influencing dialysis patient outcomesBernard Canaud, Leila Chenine, Delphine Henriet, et al.Contributions to Nephrology|May 3, 2008
Online hemodiafiltration: a multipurpose therapy for improving quality of renal replacement therapyBernard Canaud, Leila Chenine, Delphine Henriet, et al.Journal of Clinical Medicine|March 14, 2026
Advances in Membrane, Dialyzer Design, and Related Monitoring Technologies for Hemodiafiltration: Translating Bench-Side Innovations to Bedside ApplicationsAlfred Gagel, Gerhard Wiesen, Stefano Stuard, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 22, 2011
Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Associations with mortality, patient characteristics, and facility practicesRonald L Pisoni, Jennifer L Bragg-Gresham, Douglas S Fuller, et al.Jornal Brasileiro De Nefrologia|October 30, 2019
Fluid and hemodynamic management in hemodialysis patients: challenges and opportunitiesBernard Canaud, Charles Chazot, Jeroen Koomans, et al.Clinical Kidney Journal|August 8, 2015
Observation of microbubbles during standard dialysis treatmentsStephan Wagner, Christiane Rode, Ralf Wojke, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 9, 2006
Comparative testing and pharmacovigilance of biosimilarsFrancesco Locatelli, Simon RogerThe Oncologist|September 19, 2009
Is nephrology more at ease than oncology with erythropoiesis-stimulating agents? Treatment guidelines and an update on benefits and risksFrancesco Locatelli, Pere GascónPageof 55